Adverse events of recreational cannabis use during pregnancy reported to the French Addictovigilance Network between 2011 and 2020.

Autor: Bouquet E; Department of Clinical Pharmacology, Addictovigilance Center, Poitiers University Hospital, 2 rue de la Milétrie, 86 021, Poitiers, France. emilie.bouquet@chu-poitiers.fr.; Experimental and Clinical Neurosciences Laboratory, INSERM U-1084, University of Poitiers, Poitiers, France. emilie.bouquet@chu-poitiers.fr., Eiden C; Addictovigilance Center, Montpellier University Hospital, Montpellier, France., Fauconneau B; Department of Clinical Pharmacology, Addictovigilance Center, Poitiers University Hospital, 2 rue de la Milétrie, 86 021, Poitiers, France., Pion C; French National Agency for Medicines and Health Products Safety (ANSM), Saint-Denis, France., Pain S; Department of Clinical Pharmacology, Addictovigilance Center, Poitiers University Hospital, 2 rue de la Milétrie, 86 021, Poitiers, France.; Experimental and Clinical Neurosciences Laboratory, INSERM U-1084, University of Poitiers, Poitiers, France., Pérault-Pochat MC; Department of Clinical Pharmacology, Addictovigilance Center, Poitiers University Hospital, 2 rue de la Milétrie, 86 021, Poitiers, France.; Experimental and Clinical Neurosciences Laboratory, INSERM U-1084, University of Poitiers, Poitiers, France.
Jazyk: angličtina
Zdroj: Scientific reports [Sci Rep] 2022 Oct 03; Vol. 12 (1), pp. 16509. Date of Electronic Publication: 2022 Oct 03.
DOI: 10.1038/s41598-022-19197-2
Abstrakt: Cannabis is the main illicit psychoactive substance used by pregnant women in France. The aim of the present national survey was to describe adverse events (AEs) of recreational cannabis use during pregnancy reported to the French Addictovigilance Network (FAN). Spontaneous reports (SRs) of AEs related to recreational cannabis use during pregnancy were collected by the FAN between 01/01/2011 and 31/01/2021 (excluding cannabidiol and synthetic cannabinoids). Over the study period, 160 SRs involved cannabis use alone or in association with tobacco (59% of all SRs) which increased. Among the 175 maternal AEs, the most commons were psychiatric AEs experienced by 96 (64.9%) women, in particular cannabis use disorders (n = 89, 60.1%), dependence (n = 54, 36.5%) and abuse (n = 21, 14.2%). Among the 57 fetal AEs, the most common were heart rhythm disorders that affected 25 (16.9%) fetuses and intrauterine growth restriction (IUGR) (n = 20, 13.5%). Among the 140 neonatal AEs, the most common were IUGR experienced by 39 (26.3%) newborns and prematurity (n = 32, 21.6%). Twelve cases of congenital malformations were observed and 4 intrauterine/neonatal deaths. Furthermore, some of these AEs (n = 13) were unexpected. Cannabis use during pregnancy has problematic consequences for both mothers and infants who need close monitoring.
(© 2022. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje